Azithromycin in the extremely low birth weight infant for the prevention of Bronchopulmonary Dysplasia: a pilot study

BACKGROUND: Azithromycin reduces the severity of illness in patients with inflammatory lung disease such as cystic fibrosis and diffuse panbronchiolitis. Bronchopulmonary dysplasia (BPD) is a pulmonary disorder which causes significant morbidity and mortality in premature infants. BPD is pathologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballard, Hubert O, Anstead, Michael I, Shook, Lori A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1896160/
https://www.ncbi.nlm.nih.gov/pubmed/17550598
http://dx.doi.org/10.1186/1465-9921-8-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1896160/
https://www.ncbi.nlm.nih.gov/pubmed/17550598
http://dx.doi.org/10.1186/1465-9921-8-41

Ejemplares similares